Metastatic Breast Cancer Conference


Save the Date for the 3rd Annual Metastatic Breast Cancer Conference!

Saturday, March 14, 2020
9:00am-2:30pm
DoubleTree Independence
Registration for the 2020 Metastatic Conference will open on Monday, January 6th.

The Metastatic Breast Cancer Conference is designed to educate metastatic patients, breast cancer survivors, caregivers, and the general public on the ABCs of metastatic breast cancer (MBC). MBC is Stage IV breast cancer that has spread to other parts of the body such as liver, lungs, bone or brain.  The first conference of it’s kind in Northeast Ohio, the 2020 event will offer information on clinical trials, MBC research, bone health, and palliative care.

The 2020 MBC Conference will also be livestreamed via Komen Northeast Ohio’s Facebook page. Simply log onto Facebook the morning of the conference, go to Komen Northeast Ohio’s page, and click on the video link. The video will be uploaded in two parts – one before lunch and one after lunch.


2020 MBC Conference Speakers
*this information will be updated as more speakers are confirmed

Christin Hodgdon – Clinical Trials Panelist

Christine Hodgdon was a conservation biologist before her de novo triple positive metastatic breast cancer (MBC) diagnosis in 2015. She was fortunate enough to have a complete response to her treatments and with this “bonus” time, decided to leave her professional career to become a full time patient advocate. Christine has attended several scientific conferences, participated in advocacy trainings, and served as a research grant reviewer and helpline volunteer. Her passion, however, is increasing awareness and improving access to clinical trials for patients that have exhausted all of their treatment options and need help finding a trial for which they qualify. Frustrated with the inadequacies of the NCI clinical trial website, Christine created her own search algorithm to capture ALL possible trials for MBC patients and launched a website, TheStormRiders.org, which includes a searchable trial and drug database, a calendar of events, and research articles all specific to MBC patients.

Dr. Adam Brufsky – Bone Health Presentation

Adam M. Brufsky, MD, PhD, FACP, is professor of medicine at the University of Pittsburgh School of Medicine and also serves as the associate division chief for the Division of Hematology/Oncology at the University of Pittsburgh School of Medicine’s Department of Medicine. Dr. Brufsky is the medical director of the Magee-Women’s Cancer Program, part of the UPMC Hillman Cancer Center, and UPMC Hillman Cancer Center; associate director for clinical investigations at UPMC Hillman Cancer Center; and codirector of the Comprehensive Breast Cancer Center. Dr. Brufsky is board-certified in internal medicine and medical oncology. He earned a medical and doctor of philosophy degrees from the University of Connecticut School of Medicine in Farmington, Conn.; completed a residency at Brigham and Women’s Hospital, Harvard Medical School, and a fellowship at Dana-Farber Cancer Institute.

Dr. Brufsky is a member of professional organizations, such as American Medical Association, Massachusetts Medical Society, American College of Physicians, American Society of Clinical Oncology, American Association for Cancer Research, Allegheny County Medical Society, Pennsylvania Medical Society, and Pennsylvania Oncologic Society. An active researcher, Dr. Brufsky has numerous abstracts and research articles in leading journals, and is principal investigator on a number of research grants funded by the National Institutes of Health, Susan G. Komen Foundation, and US Army – Breast Cancer Research Program.

Dr. David Harris – Palliative Care Panelist

David Harris is a palliative medicine physician at The Cleveland Clinic. He finds meaning in his work when he is able to relieve the great suffering (physical, emotional, and sometimes spiritual) that comes with a cancer diagnosis.  In addition to seeing patients, David is a medical educator with a focus on teaching doctors-in-training how to communicate with patients, particularly when discussing bad news or having hard conversations. Outside of work David spends as much time as possible with his wonderful wife Julia and their pet dog, Goji. He enjoys reading and writing poetry and is trying (unsuccessfully) to learn how to garden.


The Jones-Hendryx Forever Fighter Award

The Jones-Hendryx Forever Fighter Award honors the memory of Carol Jones and Jennifer Hendryx, who both passed away from metastatic breast cancer in late 2017. Their optimism and determination throughout their fight with metastatic disease was an inspiration to others and helped Komen Northeast Ohio renew our commitment to raising awareness of Stage 4 breast cancer. The Jones-Hendryx Forever Fighter Award recognizes an individual, corporation, or organization who champions the Komen promise with the courage and limitless boundaries of Carol and Jennifer. The nominee goes beyond the scope of activist to inspire others to help in the fight against metastatic disease. Nomination forms for the 2020 Jones-Hendryx Forever Fighter Award will be available in December 2019.

Past Award Recipients

2018: Wendy Kozel

2019: Carol Smith


Sponsored by

With additional support from


In partnership with
Metavivor: Northeast Ohio Chapter, The Gathering Place, and
University Hospitals Seidman Cancer Center

Go to Top